Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (261-270 of 349) with videos related to

Pageof 35
Sort By:
Journal of Neurochemistry|September 13, 2001
Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegenerationY Levites, O Weinreb, G Maor, et al.
Journal of Neurochemistry|March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brainsE Sofic, W Paulus, K Jellinger, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's diseaseK Jellinger, L Linert, E Kienzl, et al.
Biochemical Pharmacology|April 1, 1982
Inhibition of rat liver monoamine oxidase by alpha-methyl- and N-propargyl-amine derivativesK F Tipton, J M McCrodden, A S Kalir, et al.
Advances in Neurology|July 20, 1999
Pharmacology of rasagiline (N-propargyl-1R-aminoindan)J P Finberg, I Lamensdorf, M Weinstock, et al.
Journal of Neurochemistry|August 25, 2001
Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinolW Maruyama, Y Akao, M B Youdim, et al.
Journal of Neurochemistry|August 1, 1995
Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigraM Gerlach, A X Trautwein, L Zecca, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Brain iron and ferritin in Parkinson's and Alzheimer's diseasesK Jellinger, W Paulus, I Grundke-Iqbal, et al.
Biochemical Pharmacology|February 11, 1994
The interactions of milacemide with monoamine oxidaseE M O'Brien, K F Tipton, J M McCrodden, et al.
Hormone Research|January 1, 1992
Growth-hormone-binding protein in patients with acromegalyT Amit, S Ish-Shalom, B Glaser, et al.
Pageof 35

Showing results (261-270 of 349) with videos related to

Sort By:
Pageof 35
Journal of Neurochemistry|September 13, 2001
Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegenerationY Levites, O Weinreb, G Maor, et al.
Journal of Neurochemistry|March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brainsE Sofic, W Paulus, K Jellinger, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's diseaseK Jellinger, L Linert, E Kienzl, et al.
Biochemical Pharmacology|April 1, 1982
Inhibition of rat liver monoamine oxidase by alpha-methyl- and N-propargyl-amine derivativesK F Tipton, J M McCrodden, A S Kalir, et al.
Advances in Neurology|July 20, 1999
Pharmacology of rasagiline (N-propargyl-1R-aminoindan)J P Finberg, I Lamensdorf, M Weinstock, et al.
Journal of Neurochemistry|August 25, 2001
Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinolW Maruyama, Y Akao, M B Youdim, et al.
Journal of Neurochemistry|August 1, 1995
Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigraM Gerlach, A X Trautwein, L Zecca, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Brain iron and ferritin in Parkinson's and Alzheimer's diseasesK Jellinger, W Paulus, I Grundke-Iqbal, et al.
Biochemical Pharmacology|February 11, 1994
The interactions of milacemide with monoamine oxidaseE M O'Brien, K F Tipton, J M McCrodden, et al.
Hormone Research|January 1, 1992
Growth-hormone-binding protein in patients with acromegalyT Amit, S Ish-Shalom, B Glaser, et al.
Pageof 35